Abstract
Recently, the contribution of both insufficient sleep duration and gut microbiome dysbiosis to hypertension (HTN) have been revealed, yet the profile of gut flora in hypertensive patients with insufficient sleep duration remains unknown. To examine this condition, the specific shifts in the fecal microbiome of 53 participants with or without HTN were investigated. The patients were divided into those who slept short (≤6 h) or optimal (6–9 h) duration per day. Comprehensive metagenomic sequencing analysis of fecal specimens was performed in healthy controls with sufficient sleep (s-CTR, n = 10), healthy controls with insufficient sleep (ins-CTR, n = 6), hypertensive patients with sufficient sleep (s-HTN, n = 25), and HTNs complicated by short sleep duration (ins-HTN, n = 12). We found that the α-diversity and β-diversity were quite similar between s-HTN and ins-HTN. Similarities were also observed in the enterotype distribution between s-HTN and ins-HTN subjects. In addition, the enrichment of gut bacteria was evident, such as Fusobacterium mortiferum and Roseburia inulinivorans in ins-HTN subjects. Several functional modules that were distinct between s-HTN and ins-HTN subjects were identified, which were unique to hypertensive patients with insufficient sleep duration. Overall, the data demonstrated that the gut microbial features were largely maintained in hypertensive participants with insufficient sleep duration.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout






Similar content being viewed by others
References
Buysse DJ. Sleep health: can we define it? Does it matter?. Sleep. 2014;37:9–17. https://doi.org/10.5665/sleep.3298.
Hirshkowitz M, Whiton K, Albert SM, Alessi C, Bruni O, DonCarlos L, et al. National Sleep Foundation’s sleep time duration recommendations: methodology and results summary. Sleep Health. 2015;1:40–3. https://doi.org/10.1016/j.sleh.2014.12.010.
Fernandez-Mendoza J, He F, Vgontzas AN, Liao D, Bixler EO. Interplay of objective sleep duration and cardiovascular and cerebrovascular diseases on cause-specific mortality. J Am Heart Assoc. 2019;8:e013043. https://doi.org/10.1161/JAHA.119.01304.
Li Y, Hao Y, Fan F, Zhang B. The role of microbiome in insomnia, circadian disturbance and depression. Front Psychiatry. 2018;9:669. https://doi.org/10.3389/fpsyt.2018.00669.
Farré N, Farré R, Gozal D. Sleep apnea morbidity: a consequence of microbial-immune cross-talk? Chest. 2018;154:754–9. https://doi.org/10.1016/j.chest.2018.03.001.
Broussard JL, Van Cauter E. Disturbances of sleep and circadian rhythms: novel risk factors for obesity. Curr Opin Endocrinol Diabetes Obes. 2016;23:353–9. https://doi.org/10.1097/MED.0000000000000276.
Poroyko VA, Carreras A, Khalyfa A, Khalyfa AA, Leone V, Peris E, et al. Chronic sleep disruption alters gut microbiota, induces systemic and adipose tissue inflammation and insulin resistance in mice. Sci Rep. 2016;6:35405. https://doi.org/10.1038/srep35405.
Zhang SL, Bai L, Goel N, Bailey A, Jang CJ, Bushman FD, et al. Human and rat gut microbiome composition is maintained following sleep restriction. Proc Natl Acad Sci USA. 2017;114:E1564–71. https://doi.org/10.1073/pnas.1620673114.
Triplett J, Ellis D, Braddock A, Roberts E, Ingram K, Perez E, et al. Temporal and region-specific effects of sleep fragmentation on gut microbiota and intestinal morphology in Sprague Dawley rats. Gut Microbes. 2020;11:706–20. https://doi.org/10.1080/19490976.2019.1701352.
Dashti HS, Scheer FA, Jacques PF, Lamon-Fava S, Ordovás JM. Short sleep duration and dietary intake: epidemiologic evidence, mechanisms, and health implications. Adv Nutr. 2015;6:648–59. https://doi.org/10.3945/an.115.008623.
Tobaldini E, Costantino G, Solbiati M, Cogliati C, Kara T, Nobili L, et al. Sleep, sleep deprivation, autonomic nervous system and cardiovascular diseases. Neurosci Biobehav Rev. 2017;74:321–9. https://doi.org/10.1016/j.neubiorev.2016.07.004.
Beccuti G, Pannain S. Sleep and obesity. Curr Opin Clin Nutr Metab Care. 2011;14:402–12. https://doi.org/10.1097/MCO.0b013e3283479109.
Gangwisch JE. A review of evidence for the link between sleep duration and hypertension. Am J Hypertens. 2014;27:1235–42. https://doi.org/10.1093/ajh/hpu071.
Wang Y, Mei H, Jiang YR, Sun WQ, Song YJ, Liu SJ, et al. Relationship between duration of sleep and hypertension in adults: a meta-analysis. J Clin Sleep Med. 2015;11:1047–56. https://doi.org/10.5664/jcsm.5024.
Zhang H, Zhao X, Li Y, Mao Z, Huo W, Jiang J, et al. Night sleep duration and sleep initiation time with hypertension in Chinese rural population: the Henan Rural Cohort. Eur J Public Health. 2020;30:164–70. https://doi.org/10.1093/eurpub/ckz142.
Li J, Yang X, Zhou X, Cai J. The role and mechanism of intestinal flora in blood pressure regulation and hypertension development. Antioxid Redox Signal. 2020. https://doi.org/10.1089/ars.2020.8104.
Yang T, Santisteban MM, Rodriguez V, Li E, Ahmari N, Carvajal JM. et al. Gut dysbiosis is linked to hypertension. Hypertension. 2015;65:1331–40. https://doi.org/10.1161/HYPERTENSIONAHA.115.05315.
Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G, et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017;5:14. https://doi.org/10.1186/s40168-016-0222-x.
Wang C, Bangdiwala SI, Rangarajan S, Lear SA, AlHabib KF, Mohan V, et al. Association of estimated sleep duration and naps with mortality and cardiovascular events: a study of 116,632 people from 21 countries. Eur Heart J. 2019;40:1620–9. https://doi.org/10.1093/eurheartj/ehy695.
Watson NF, Badr MS, Belenky G, Bliwise DL, Buxton OM, Buysse D, et al. Recommended amount of sleep for a healthy adult: a joint consensus statement of the American Academy of Sleep Medicine and Sleep Research Society. Sleep. 2015;38:843–4. https://doi.org/10.5665/sleep.4716.
Siezen RJ, Kleerebezem M. The human gut microbiome: are we our enterotypes? Micro Biotechnol. 2011;4:550–3. https://doi.org/10.1111/j.1751-7915.2011.00290.x.
Huson DH, Auch AF, Qi J, Schuster SC. MEGAN analysis of metagenomic data. Genome Res. 2007;17:377–86. https://doi.org/10.1101/gr.5969107.
Bäckhed F, Roswall J, Peng Y, Feng Q, Jia H, Kovatcheva-Datchary P, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe. 2015;17:690–703. https://doi.org/10.1016/j.chom.2015.04.004.
Mansukhani MP, Covassin N, Somers VK. Apneic sleep, insufficient sleep, and hypertension. Hypertension. 2019;73:744–56. https://doi.org/10.1161/HYPERTENSIONAHA.118.11780.
Amitay EL, Werner S, Vital M, Pieper DH, Höfler D, Gierse IJ, et al. Fusobacterium and colorectal cancer: causal factor or passenger? Results from a large colorectal cancer screening study. Carcinogenesis. 2017;38:781–8. https://doi.org/10.1093/carcin/bgx053.
George WL, Kirby BD, Sutter VL, Citron DM, Finegold SM. Gram-negative anaerobic bacilli: their role in infection and patterns of susceptibility to antimicrobial agents. II. Little-known Fusobacterium species and miscellaneous genera. Rev Infect Dis. 1981;3:599–626. https://doi.org/10.1093/clinids/3.3.599.
Pryde SE, Duncan SH, Hold GL, Stewart CS, Flint HJ. The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett. 2002;217:133–9. https://doi.org/10.1111/j.1574-6968.2002.tb11467.x.
De Preter V, Machiels K, Joossens M, Arijs I, Matthys C, Vermeire S, et al. Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut. 2015;64:447–58. https://doi.org/10.1136/gutjnl-2013-306423.
Takahashi K, Nishida A, Fujimoto T, Fujii M, Shioya M, Imaeda H, et al. Reduced abundance of butyrate-producing bacteria species in the fecal microbial community in Crohn’s Disease. Digestion. 2016;93:59–65. https://doi.org/10.1159/000441768.
Hering NA, Fromm A, Bücker R, Gorkiewicz G, Zechner E, Högenauer C, et al. Tilivalline- and tilimycin-independent effects of klebsiella oxytoca on tight junction-mediated intestinal barrier impairment. Int J Mol Sci. 2019;20:5595. https://doi.org/10.3390/ijms20225595.
Alkhalaf LM, Ryan KS. Biosynthetic manipulation of tryptophan in bacteria: pathways and mechanisms. Chem Biol. 2015;22:317–28. https://doi.org/10.1016/j.chembiol.2015.02.005.
Li C, Chen W, Zhang M, Zhang C, Cao B, Dong B, et al. Modulatory effects of Xihuang Pill on lung cancer treatment by an integrative approach. Biomed Pharmacother. 2020;130:110533. https://doi.org/10.1016/j.biopha.2020.110533.
Zhang X, Xu L, Shen J, Cao B, Cheng T, Zhao T, et al. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum. Biochim Biophys Acta. 2013;1832:1207–16. https://doi.org/10.1016/j.bbadis.2013.03.009.
Miyagi Y, Higashiyama M, Gochi A, Akaike M, Ishikawa T, Miura T, et al. Plasma free amino acid profiling of five types of cancer patients and its application for early detection. PLoS ONE. 2011;6:e24143. https://doi.org/10.1371/journal.pone.0024143.
Chin JP, McGrath JW, Quinn JP. Microbial transformations in phosphonate biosynthesis and catabolism, and their importance in nutrient cycling. Curr Opin Chem Biol. 2016;31:50–7. https://doi.org/10.1016/j.cbpa.2016.01.010.
Tang J, Yan Y, Zheng JS, Mi J, Li D. Association between erythrocyte membrane phospholipid fatty acids and sleep disturbance in Chinese children and adolescents. Nutrients. 2018;10:344. https://doi.org/10.3390/nu10030344.
Song JJ, Ma Z, Wang J, Chen LX, Zhong JC. Gender differences in hypertension. J Cardiovasc Transl Res. 2020;13:47–54. https://doi.org/10.1007/s12265-019-09888-z.
Funding
This work was supported by the National Natural Science Foundation of China (81670214, 81870308, and 81970271), the Natural Science Foundation of Beijing Municipality (7172080, 7204242), the Capital Medical University Research and Development Fund (1200020102), and the National Nature Cultivation Fund of Beijing Chaoyang Hospital (CHPY202050).
Author information
Authors and Affiliations
Contributions
JL, XY, and JJ conceived the study, directed the project, designed the experiments. JL, JJ, and YD interpreted the results, and wrote the manuscript. PW, KZ, CH, JC, and JZ recruited and collected the clinical details from the subjects. JJ, YD, and JL analyzed the data. XY, JJ, YD, and JL revised the manuscript. JJ and YD contributed equally to this work and are jointly first authors.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Jiao, J., Dong, Y., Wang, P. et al. Profile of gut flora in hypertensive patients with insufficient sleep duration. J Hum Hypertens 36, 390–404 (2022). https://doi.org/10.1038/s41371-021-00529-0
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41371-021-00529-0


